# Salsolinol-Containing Senna silvestris Exerts Antiviral Activity Against Hepatitis B Virus

## TL;DR

A compound in Senna silvestris, salsolinol, shows antiviral activity against hepatitis B virus in cell studies.

## Contribution

Identification of salsolinol from Senna silvestris as a potential antiviral agent against HBV.

## Key findings

- Salsolinol inhibited HBV DNA and core HBV DNA in HepG2.2.15 cells.
- Commercial salsolinol showed antiviral activity with an approximate MIC of 12 µM.
- Salsolinol's potential as a dual agent against HBV and HIV is suggested for further study.

## Abstract

Several natural products have been shown to display antiviral activity against the hepatitis B virus (HBV), among a number of other viruses. In a previous study, the hydro-alcoholic extracts (n = 66) of 31 species from the Venezuelan Amazonian rain forest were tested on the hepatoma cell line HepG2.2.15, which constitutively produces HBV. One of the species that exerted inhibitory activity on HBV replication was Senna silvestris. The aim of this study was the bioassay-guided purification of the ethanol fraction of leaves of S. silvestris, which displayed the most significant inhibitory activity against HBV. After solvent extraction and two rounds of reverse-phase HPLC purification, NMR analysis identified salsolinol as the compound that may exert the desired antiviral activity. The purified compound exerted inhibition of both HBV DNA and core HBV DNA. Pure salsolinol obtained from a commercial source also displayed anti-HBV DNA inhibition, with an approximate MIC value of 12 µM. Although salsolinol is widely used in Chinese traditional medicine to treat congestive heart failure, it has also been associated with Parkinson’s disease. More studies are warranted to analyze the effect of changes in its chemical conformation, searching for potent antiviral, perhaps dual agents against HBV and HIV, with reduced toxicity.